High ERCC1 expression predicts cisplatin-based chemotherapy resistance and poor outcome in unresectable squamous cell carcinoma of head and neck in a betel-chewing area.
about
Genome stability pathways in head and neck cancersHigh level expression of AMAP1 protein correlates with poor prognosis and survival after surgery of head and neck squamous cell carcinoma patientsAssessment and Improvement of Quality of Life in Patients Undergoing Treatment for Head and Neck Cancer.DNA repair biomarkers XPF and phospho-MAPKAP kinase 2 correlate with clinical outcome in advanced head and neck cancerBetel nut chewing history is an independent prognosticator for smoking patients with locally advanced stage IV head and neck squamous cell carcinoma receiving induction chemotherapy with docetaxel, cisplatin, and fluorouracil.Clinical observation of gene expression-guided chemoradiation therapy for nonsurgical esophageal squamous cell carcinoma patients: a retrospective analysis of 36 cases.ERCC1 is a prognostic biomarker in locally advanced head and neck cancer: results from a randomised, phase II trial.The prognostic and predictive value of excision repair cross-complementation group 1 (ERCC1) protein in 1288 patients with head and neck squamous cell carcinoma treated with platinum-based therapy: a meta-analysis.Comparative molecular profiling of HPV-induced squamous cell carcinomas.Cell cycle association and hypoxia regulation of excision repair cross complementation group 1 protein (ERCC1) in tumor cells of head and neck cancer.Cytokine-Induced Killer Cells Modulates Resistance to Cisplatin in the A549/DDP Cell Line.
P2860
Q28391355-FC4F0B54-DA7B-4523-9AF9-24968120D7FBQ28658539-D369A6CE-8ABF-479A-91FF-0214336F404EQ33752449-D3647C1D-B656-4922-A755-7C2CD0181117Q35206363-AEA2D286-8A39-47DD-90FC-DB45A413524EQ36714584-25084F89-4B7E-445E-AE70-AE6558D570F2Q37138374-A9C2C658-6C08-4477-8EB4-5C95CEF50570Q37235591-1889485B-5A33-4821-854B-CC5F7FAB5DECQ38548142-A81DC97C-0035-4A10-8E77-EF3CE8373524Q40193932-D834C319-8033-4290-9228-C9EA754BB180Q41782195-E61467EB-E8D5-4C79-99A6-1C81C7BEF644Q46028686-2898EB6B-E0B4-4FEE-B0D5-66FF1B050453
P2860
High ERCC1 expression predicts cisplatin-based chemotherapy resistance and poor outcome in unresectable squamous cell carcinoma of head and neck in a betel-chewing area.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
High ERCC1 expression predicts ...... neck in a betel-chewing area.
@ast
High ERCC1 expression predicts ...... neck in a betel-chewing area.
@en
High ERCC1 expression predicts ...... neck in a betel-chewing area.
@nl
type
label
High ERCC1 expression predicts ...... neck in a betel-chewing area.
@ast
High ERCC1 expression predicts ...... neck in a betel-chewing area.
@en
High ERCC1 expression predicts ...... neck in a betel-chewing area.
@nl
prefLabel
High ERCC1 expression predicts ...... neck in a betel-chewing area.
@ast
High ERCC1 expression predicts ...... neck in a betel-chewing area.
@en
High ERCC1 expression predicts ...... neck in a betel-chewing area.
@nl
P2093
P2860
P356
P1476
High ERCC1 expression predicts ...... neck in a betel-chewing area.
@en
P2093
Chang-Han Chen
Chih-Yen Chien
Hsin-Ting Tsai
Shau-Hsuan Li
Tai-Jan Chiu
Yi-Ju Chen
P2860
P2888
P356
10.1186/1479-5876-9-31
P577
2011-03-23T00:00:00Z
P5875
P6179
1024989235